Clinical Trial Update: Evaluate the Efficacy and Safety of MEDITOXIN in Treatment of Primary Axillary Hyperhidrosis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating MEDITOXIN for primary axillary hyperhidrosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Focal Axillary Hyperhidrosis
• Hyperhidrosis

Drugs mentioned

• Meditoxin (botulinum toxin type A)

Snippet

Sponsor: Medy-Tox | Conditions: Hyperhidrosis Primary Focal Axilla | Phase 3 | Status: COMPLETED